Hong-Sin Kim
Presidente en Korea Stem Cell Bank Co., Ltd. .
Perfil
Hong-Sin Kim is currently the Chairman of Korea Stem Cell Bank Co., Ltd.
and a Professor at Konkuk University.
In the past, he served as an Independent Director at ChoA Pharmaceutical Co., Ltd.
and BIOVILL Co., Ltd.
from 2012 to 2018.
Cargos activos de Hong-Sin Kim
Empresas | Cargo | Inicio |
---|---|---|
Konkuk University | Corporate Officer/Principal | - |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Presidente | - |
Antiguos cargos conocidos de Hong-Sin Kim.
Empresas | Cargo | Fin |
---|---|---|
KSCB CO LTD | Presidente | - |
CHOA PHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Empresas privadas | 2 |
---|---|
BIOVILL Co., Ltd.
BIOVILL Co., Ltd. Industrial SpecialtiesProcess Industries BIOVILL Co., Ltd. engages in the manufacture and sale of functional materials. Its products include coloring materials for plastics, inks for plastic printing, surface treatment materials, polyvinyl compound, frame structure, and other products. The company was founded in April 1976 and is headquartered in Yangsan-si, South Korea. | Process Industries |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Hong-Sin Kim